Cherayil BJ, Ellenbogen S, Shanmugam NN
This study population was then divided into 3 cohorts: (1) semaglutide cohort 45,797 patients who were first-time prescribed semaglutide, (2) non-GLP1-RA anti-obesity medication cohort 38,028 patients who were first-time prescribed non-GLP-1RA anti-obesity medications but not semaglutide and (3) naltrexone/topiramate cohort 16,676 patients who were first time prescribed naltrexone and topiramate but not semaglutide
Brand-name Wegovy for weight management can cost $199 to $499 per month without insurance
Trial 7 Treatment Effect for MACE and its Components Figure 1: Time to First Occurrence of a MACE in Trial 7 Data from the in-trial period based on full analysis set defined as all randomized patients
Understanding Mast Cell Activation Syndrome (MCAS) Mast Cell Activation Syndrome (MCAS) refers to a condition where mast cells become hyperreactive they're essentially on a hair trigger
Administration can be by injection or oral form depending on the protocol